Medical Condition News

RSS

Alzheimer's Association recognizes four scientists for achievements in Alzheimer research at AAICAD 2010

The Alzheimer's Association recognized four scientists for their extraordinary achievements in advancing Alzheimer research at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu, Hawaii.

12 Jul 2010

Fussy eating may be an “eating disorder” say researchers

Picky and fussy eaters are not just being difficult to please say U.S. researchers. They may be suffering from an eating disorder like anorexia or bulimia. Soon the disorder is to have an official name and the American Psychiatric Association plans to call them “selective eaters”.

11 Jul 2010

Diabetes reform plans do not please the AMA

In a bid to reform the way long term illnesses like diabetes are managed in Australia, the federal government announced a $436 million scheme to be introduced from 2012.

11 Jul 2010

Florbetaben PET tracer data to be presented at Alzheimer's Association ICAD 2010

Bayer HealthCare Pharmaceuticals, Inc. today announced that data on the company's investigational PET amyloid imaging tracer Florbetaben (BAY 94-9172) will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 in Honolulu July 10 – 15.

9 Jul 2010

Lantheus signs new manufacturing, supply agreement with MDS Nordion for Mo-99

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that it has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m). Mo-99 is used in Lantheus Medical Imaging's TechneLite® (Technetium Tc99m Generator) generators, which are sold throughout the world, and which produce Tc-99m, a medical isotope widely used in nuclear medicine imaging.

9 Jul 2010

MJFF awards $1.1M to six different projects for validating potential therapeutic targets for PD

The Michael J. Fox Foundation for Parkinson's Research today announced $1.1 million in total funding to six different projects aimed at validating potential therapeutic targets for Parkinson's disease.

9 Jul 2010

URI engineers develop new controlled drug delivery system using nanoparticles embedded in liposome

A new system for the controlled delivery of pharmaceutical drugs has been developed by a team of University of Rhode Island chemical engineers using nanoparticles embedded in a liposome that can be triggered by non-invasive electromagnetic fields.

9 Jul 2010

Namaste Charter School to use physical fitness and nutrition in childhood obesity prevention

At a time when the nation is focused on solving the problem of childhood obesity within a generation, and when school lunch revolutions are in full force - an inner city school in Chicago has found a winning formula. Namaste Charter School has a unique mission to use physical fitness and nutrition as avenues to reach higher student achievement, and this dedication to both academics and personal health has resulted in national recognition and a new, larger permanent home.

9 Jul 2010

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

Catalyst Pharmaceutical Partners, Inc. today announced that the European Patent Office (EPO) granted to Brookhaven Science Associates/Brookhaven National Laboratory (Brookhaven) a European patent for the use of vigabatrin for the prevention of addiction to opioids (e.g., oxycodone, hydrocodone) used in pain management.

9 Jul 2010

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Pfizer Inc, the world's leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be presented at the World Federation of Hemophilia 2010 Congress taking place July 10-14, 2010, in Buenos Aires, Argentina. Key research includes a pre-clinical evaluation of recombinant factor Xa as a potential new approach to restoring hemostasis, as well as a study assessing the potential for an engineered recombinant factor VIIa molecule to improve therapeutic outcomes in mouse models of hemophilia.

9 Jul 2010

Semuloparin reduces incidence of VTE in orthopedic surgery patients, study finds

An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in a large clinical program being lead by a steering committee chaired by McMaster University professor Dr. Alexander Turpie.

9 Jul 2010

Study shows association between obesity and GERD in children

Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity.

9 Jul 2010

Integra LifeSciences launches DuraGen Plus Dural Regeneration Matrix - Spinal Matrix

Integra LifeSciences Holdings Corporation announced today the launch of DuraGen Plus® Dural Regeneration Matrix - Spinal Matrix, an absorbable and sutureless collagen onlay indicated as a dura substitute for the repair of dura mater.

9 Jul 2010

Phase II trial results of TB-402 presented at International Congress on Thrombosis

BioInvent International AB and ThromboGenics NV announce that the positive results from a Phase II trial of TB-402 (Anti-Factor VIII antibody) were presented at the 21st International Congress on Thrombosis in Milan, Italy yesterday. TB-402 is a novel, long acting anticoagulant that is being developed as a single injection for the prevention of venous thromboembolism following orthopaedic surgery.

9 Jul 2010

Community-based wellness program helps reduce obesity, chronic inflammatory diseases: Study

Tackling weight loss, risk of chronic disease and overall well-being as part of a like-minded social community can dramatically influence an individual's success rate, according to a new study published in the July 2010 issue of the Center for Disease Control's Preventing Chronic Disease journal.

9 Jul 2010

Derma Sciences submits 510(k) application to FDA for MEDIHONEY Gel Wound & Burn Dressing

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, announces the achievement of regulatory and commercial milestones.

9 Jul 2010

Allergan receives UK MHRA authorisation of BOTOX for prophylaxis of headache in chronic migraine

Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.

9 Jul 2010

PTSD disability claims for veterans become easier with new VA regulations

While The American Legion welcomed new VA regulations that make it easier for veterans to claim disabilities from post-traumatic stress disorder, it also urged the agency to allow private practitioners to diagnose and treat the condition.

9 Jul 2010

DGP/tTG Screen assay may be best initial test for suspected celiac disease: Study

Diagnosis of celiac disease is based on a characteristic enteropathy in an intestinal biopsy and evidence that these changes are gluten-triggered. The appropriate use of simpler and more accurate tools would add reliability to the diagnosis of celiac disease. Thus, the celiac disease-related serology might have a key role in defining new diagnostic standards for celiac disease.

9 Jul 2010

Oklahoma City ProCure Proton Therapy Center celebrates first-year anniversary

Past and present patients, families, friends, staff and physicians of ProCure Proton Therapy Center in Oklahoma City commemorated a year of achievements at a celebratory luncheon Thursday at the center in northwest Oklahoma City.

9 Jul 2010

Medical Condition News

Alzheimer's Association recognizes four scientists for achievements in Alzheimer research at AAICAD 2010

Fussy eating may be an “eating disorder” say researchers

Diabetes reform plans do not please the AMA

Florbetaben PET tracer data to be presented at Alzheimer's Association ICAD 2010

Lantheus signs new manufacturing, supply agreement with MDS Nordion for Mo-99

MJFF awards $1.1M to six different projects for validating potential therapeutic targets for PD

URI engineers develop new controlled drug delivery system using nanoparticles embedded in liposome

Namaste Charter School to use physical fitness and nutrition in childhood obesity prevention

EPO grants Brookhaven patent for use of vigabatrin in prevention of addiction to opioids

Pfizer to present results of hemophilia studies at WFH 2010 Congress

Semuloparin reduces incidence of VTE in orthopedic surgery patients, study finds

Study shows association between obesity and GERD in children

Integra LifeSciences launches DuraGen Plus Dural Regeneration Matrix - Spinal Matrix

Phase II trial results of TB-402 presented at International Congress on Thrombosis

Community-based wellness program helps reduce obesity, chronic inflammatory diseases: Study

Derma Sciences submits 510(k) application to FDA for MEDIHONEY Gel Wound & Burn Dressing

Allergan receives UK MHRA authorisation of BOTOX for prophylaxis of headache in chronic migraine

PTSD disability claims for veterans become easier with new VA regulations

DGP/tTG Screen assay may be best initial test for suspected celiac disease: Study

Oklahoma City ProCure Proton Therapy Center celebrates first-year anniversary

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News